Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) P/E Ratio History
Insufficient DataInsufficient historical P/E data to classify valuation. · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
Compared to the Consumer Cyclical sector median P/E of 21.4x, BYAH trades at a 193% premium to its sector peers. The sector includes 309 companies with P/E ratios ranging from 0.1x to 184.9x.
Relative to the broader market, BYAH commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BYAH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BYAH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
BYAH P/E vs Peers
Beauty Services and Personal Care Brands peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 3.7Lowest | - | +307%Best | |
| $108M | 25.8 | 6.03Best | +16% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BYAH — Frequently Asked Questions
Quick answers to the most common questions about buying BYAH stock.
What is BYAH's P/E ratio?
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) trailing twelve-month P/E ratio is 62.8x, based on TTM diluted EPS of N/A. The 5-year average P/E is N/A and the historical range spans N/A to N/A.
Is BYAH stock overvalued or undervalued?
BYAH current P/E: 62.8x. 5-year average P/E: N/A. Percentile: N/A.
Is BYAH stock expensive?
BYAH is fairly valued relative to its own history. The current P/E of 62.8x is near the 5-year average of N/A (N/A percentile of historical range).
What is BYAH's historical P/E range?
Over the past 5 years, BYAH's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of 62.8x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.
How does BYAH's P/E compare to the S&P 500?
BYAH trades at 62.8x P/E versus the S&P 500 median of 25.1x. The 150% premium to the market typically reflects higher expected earnings growth or quality.
How does BYAH's valuation compare to Consumer Cyclical peers?
Park Ha Biological Technology Co., Ltd. Ordinary Shares P/E of 62.8x compares to the Consumer Cyclical sector median of 21.4x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is BYAH's PEG ratio?
BYAH PEG ratio is N/A, based on a P/E of 62.8x and EPS growth of -43.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is BYAH's earnings yield?
BYAH earnings yield is 1.59%, the inverse of its 62.8x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.